G-test在肝细胞癌筛查中的诊断价值

肝脏 ›› 2021, Vol. 26 ›› Issue (5): 518-521.

G-test在肝细胞癌筛查中的诊断价值

杨雪, 陆观珠, 杜成坎, 王博成, 许洁, 包玉洁

201900 上海交通大学医学院附属第九人民医院感染科(杨雪,陆观珠,许洁,包玉洁),影像科(王博成);
上海交通大学医学院附属儿童医院检验科(杜成坎)

收稿日期:2020-12-31 出版日期:2021-05-31 发布日期:2021-06-17
通讯作者: 包玉洁,Email:yujie.bao@shsmu.edu.cn
基金资助:
国家自然科学基金(82002486)

The diagnostic value of G-test in the early screening for primary hepatocellular carcinoma

YANG Xue¹, LU Guan-zhu¹, DU Cheng-kan², WANG Bo-cheng³, XU Jie¹, BAO Yu-jie¹

1. Department of Infectious Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201900, China;
2. Department of Clinical Laboratory, Children's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 200040, China;
3. Department of Radiology, the Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai 201900, China

Received:2020-12-31 Online:2021-05-31 Published:2021-06-17
Contact: BAO Yu-jie,Email:yujie.bao@shsmu.edu.cn

摘要/Abstract

摘要： 目的提高肝细胞癌(hepatocellular carcinoma,HCC)患者的诊断对其生存率具有重要的意义。甲胎蛋白(alpha-fetoprotein,AFP)普遍应用于HCC的筛查与诊断,但是其敏感度和特异度存在不足,因此有必要进一步筛选相关标记物提高HCC的诊断率。方法对临床诊断为HCC患者及考虑存在HCC高危因素的慢性肝病患者中,对比分析荧光毛细血管法寡糖链检测(G-test)和AFP单独或联合应用于HCC的诊断率。结果本研究共纳入73名HCC及考虑存在HCC高危因素的非HCC慢性肝病患者。经病理学或影像学联合AFP确诊HCC患者30人。受试者操作特征曲线(ROC)下面积(AUC)分析得到:单独检测G-test(AUC:0.701)和AFP(AUC:0.680)二者的敏感性无显著差异(P=0.764 8)。进一步研究发现G-test联合AFP(AUC:0.698)检测的灵敏度(90.0%)和特异度(93.0%)显著高于单独AFP的检测(AUC:0.671)。结论 G-test联合AFP能够提高HCC的诊断率。

关键词: 肝细胞癌, G-test, AFP, ROC-AUC, 回顾性研究

Abstract: Objective Early diagnosis is of vital clinical significance in promoting survival in patients with primary hepatocellular carcinoma (HCC). Alpha-fetoprotein (AFP) has been widely applied in the diagnosis of primary HCC, but its sensitivity and specificity are unsatisfactory. Therefore, it is necessary to identify novel diagnostic biomarkers to improve the diagnosis efficacy.Methods Patients with clinically diagnosed HCC or at high risk of HCC in our hospital from January 2019 to August 2019 were enrolled. The diagnostic value of AFP, oligosaccharide chain detection (G-test), and their combination for HCC was analyzed.Results A total of 73 patients were included. Among them, 30 HCC patients were confirmed by pathology or imaging combined with AFP. The area under the receiver operating characteristic curve (ROC-AUC) of G-test was 0.701, and the ROC-AUC of AFP was 0.680. There was no significant difference in the sensitivity between them (P=0.7648). Furthermore, the ROC-AUC of the combination of G-test and AFP was 0.671. The sensitivity and the specificity of the combination were 90.0% and 93.0%, which were significantly higher those of AFP alone.Conclusion G-test combined with AFP could improve diagnostic yield for HCC.

Key words: Hepatocellular carcinoma, Glycan-test, Alpha-fetoprotein, Area under the receiver operating characteristic curve, Retrospective study

杨雪, 陆观珠, 杜成坎, 王博成, 许洁, 包玉洁. G-test在肝细胞癌筛查中的诊断价值[J]. 肝脏, 2021, 26(5): 518-521.

YANG Xue, LU Guan-zhu, DU Cheng-kan, WANG Bo-cheng, XU Jie, BAO Yu-jie. The diagnostic value of G-test in the early screening for primary hepatocellular carcinoma[J]. Chinese Hepatolgy, 2021, 26(5): 518-521.

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018,68:394-424.
[2] Sharma R. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Jpn J Clin Oncol, 2020.
[3] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016,66:115-132.
[4] 吴孟超. 肝癌. 北京:人民卫生出版社, 2010:58-61.
[5] Miyahara K, Nouso K, Dohi C, et al. Alteration of N-glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma. Hepatol Res, 2015,45:986-993.
[6] Na K, Kim M, Kim CY, et al. Potential Regulatory Role of Human-Carboxylesterase-1 Glycosylation in Liver Cancer Cell Growth. J Proteome Res, 2020.
[7] Zhang S, Cao X, Liu C, et al. N-glycopeptide Signatures of IgA2 in Serum from Patients with Hepatitis B Virus-related Liver Diseases. Mol Cell Proteomics, 2019,18:2262-2272.
[8] Zhao T, Jia L, Li J, et al. Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations. Front Oncol, 2020,10:496.
[9] 陆荫英,赵海涛,程家敏,等. 肝胆肿瘤分子诊断临床应用专家共识. 临床肝胆病杂志, 2020,36:1482-1488.
[10] An HJ, Miyamoto S, Lancaster KS, et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res, 2006,5:1626-1635.
[11] Kirmiz C, Li B, An HJ, et al. A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics, 2007,6:43-55.
[12] Liu XE, Desmyter L, Gao CF, et al. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology, 2007,46:1426-1435.

[1]	何春梅, 莫之婧. 基于生物信息学分析鉴定肝细胞癌预后生物标志物[J]. 肝脏, 2021, 26(5): 522-526.
[2]	苏丹, 张伟伟. 非HBV和HCV相关性肝细胞癌患者临床特征及预后影响因素分析[J]. 肝脏, 2021, 26(4): 384-387.
[3]	张彬彬, 郁皓, 曹斐, 吴晓霞, 单永锋, 王昊楠, 刘慧. 长链非编码RNA CCAT1可作为肝细胞癌血浆标志物并预测其治疗效果[J]. 肝脏, 2021, 26(4): 392-394.
[4]	李芳芳, 翁亚丽, 李响, 王茜, 浦立勇, 刘凌翔, 杨芬, 孙阿雷. 寡糖链检测对HBV相关性肝细胞癌的诊断价值[J]. 肝脏, 2021, 26(4): 395-399.
[5]	王蔚, 李慧艳, 刘华. 纤维蛋白原/前白蛋白比值、γ-谷氨酰转肽酶/血小板比值在甲胎蛋白阴性肝细胞癌中的应用价值[J]. 肝脏, 2021, 26(3): 270-272.
[6]	陈育锋, 朱泽远, 程影, 祁良. Gd-EOB-DTPA MRI联合超声造影对肝硬化背景<2 cm肝癌的诊断[J]. 肝脏, 2021, 26(3): 273-275.
[7]	韦小芳, 欧传话, 李绍龙, 毛小玲. 免疫组化法检测肝癌组织Twist表达的临床意义[J]. 肝脏, 2021, 26(3): 281-283.
[8]	张波, 张余芬. HCV相关肝细胞癌组织内HCV RNA及核心蛋白水平表达研究[J]. 肝脏, 2021, 26(2): 179-181.
[9]	张达利, 周霞, 冯丹妮, 贺希, 王洪波, 高银杰, 孙艳玲, 张利娟, 刘振文, 刘鸿凌. 不同肝移植标准下原发性肝癌患者的预后分析[J]. 肝脏, 2020, 25(9): 915-918.
[10]	陈晖, 左琳琳, 李木松, 刘猛. 肝细胞癌患者射频消融术治疗10年长期有效性分析[J]. 肝脏, 2020, 25(9): 922-925.
[11]	郭克锋, 常英英, 李宗民, 柳玉花. LncRNA SNHG7在肝癌组织中的表达水平及临床意义[J]. 肝脏, 2020, 25(9): 1008-1010.
[12]	张志生, 孔庆利, 梁志鹏. 不同AFP水平肝细胞癌患者手术后5年生存期比较的回顾性分析[J]. 肝脏, 2020, 25(8): 813-815.
[13]	杨大才, 吴宏, 朱廷玲. 超声造影肝脏影像报告与数据系统在LR--3、LR-4、LR-5类病灶中的应用价值[J]. 肝脏, 2020, 25(8): 816-818.
[14]	李明桧, 唐荣, 陈孙斌. 基于LI-RADS分类标准的超声造影技术对肝细胞癌诊断的可行性研究[J]. 肝脏, 2020, 25(8): 822-824.
[15]	李堃, 何海林. CT全肿瘤灌注参数值与肝细胞癌病理分级、微血管侵犯的关系[J]. 肝脏, 2020, 25(8): 828-830.